PhysIQ Inc. Receives FDA Clearance of Continuous Ambulatory Respiration Rate Algorithm Enabling Artificial Intelligence-based Analytics for Biopharma Companies and Payers

16

CHICAGO–(BUSINESS WIRE)–PhysIQ announced it has received 510(k) clearance from the FDA for their algorithm to continuously determine respiration rate in ambulatory patients http://www.businesswire.com/news/home/20190731005232/en/PhysIQ-Receives-FDA-Clearance-Continuous-Ambulatory-Respiration/?feedref=JjAwJuNHiystnCoBq_hl-WFAllVCLJFCqzlmaJ8DKHU4plfPZtlGYRDUHCSmgbii6XkLWuQZD-HgGRnjQvCyg3iCfEFIaJW7-otp9V1XQiK2eHTJy3ZqOEt7kKgLu20J